News & Updates
Filter by Specialty:
COVID-19 vaccines promising in multiple myeloma patients
Vaccination against SARS-CoV-2 appears to lead to favourable outcomes in multiple myeloma (MM) patients who contract the coronavirus disease 2019 (COVID-19), even in the presence of negative prognostic factors, a recent study has found.
COVID-19 vaccines promising in multiple myeloma patients
05 Jan 2022
Abdominal adipose tissue radiodensity predicts survival after colorectal cancer
Adipose tissue radiodensity is significantly associated with the risk of death in patients with nonmetastatic colorectal cancer (CRC), independent of body mass index and changes in body weight, results of a study have shown.
Abdominal adipose tissue radiodensity predicts survival after colorectal cancer
04 Jan 2022
Systemic inflammation linked to physical, cognitive symptoms of depression
Systemic inflammation is associated with symptom-specific rather than generalized effects on depression, suggests a recent study.
Systemic inflammation linked to physical, cognitive symptoms of depression
04 Jan 2022
Closed-loop trumps sensor-augmented pumps for older T1D patients
A closed-loop insulin delivery system is both effective and safe for the management of type 1 diabetes (T1D) in older adults, according to a recent study. As compared with sensor-augmented pump systems, closed-loop deliveries yield greater time-in-range (TIR) outcomes and help minimize time spent in hypoglycaemic range overnight.
Closed-loop trumps sensor-augmented pumps for older T1D patients
04 Jan 2022
Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
In women with hormone-receptor positive advanced breast cancer (HR+ aBC), the addition of the class I selective histone deacetylase (HDAC) inhibitor entinostat to exemestane appeared to be better than treatment with exemestane alone in terms of survival benefit, according to a phase III trial from China.
